SBC Medical (SBC) | Financial Analysis & Statements
SBC Medical Group Holdings Inc. Small-cap Industrials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
39.6M
Gross Profit
28.9M
73.11%
Operating Income
12.8M
32.47%
Net Income
14.3M
36.09%
EPS (Diluted)
$0.14
Balance Sheet Metrics
Total Assets
380.4M
Total Liabilities
117.1M
Shareholders Equity
263.3M
Debt to Equity
0.44
Cash Flow Metrics
Operating Cash Flow
38.4M
Free Cash Flow
50.7M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
SBC Medical Income Statement From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 173.6M | 205.4M | 193.5M | 174.2M |
| Cost of Goods Sold | 46.3M | 49.4M | 56.2M | 59.3M |
| Gross Profit | 127.3M | 156.1M | 137.3M | 114.8M |
| Gross Margin % | 73.3% | 76.0% | 70.9% | 65.9% |
| Operating Expenses | ||||
| Research & Development | - | - | - | - |
| Selling, General & Administrative | 59.8M | 70.7M | 66.2M | 93.5M |
| Other Operating Expenses | - | - | - | - |
| Total Operating Expenses | 59.8M | 70.7M | 66.2M | 93.5M |
| Operating Income | 67.5M | 85.4M | 71.1M | 21.3M |
| Operating Margin % | 38.9% | 41.6% | 36.7% | 12.3% |
| Non-Operating Items | ||||
| Interest Income | 198.3K | 19.9K | 86.7K | 472.4K |
| Interest Expense | 160.6K | 28.3K | 45.3K | 31.4K |
| Other Non-Operating Income | 14.5M | -11.9M | 2.5M | 1.9M |
| Pre-tax Income | 82.1M | 73.5M | 73.6M | 23.7M |
| Income Tax | 31.0M | 26.8M | 35.0M | 18.1M |
| Effective Tax Rate % | 37.8% | 36.4% | 47.6% | 76.5% |
| Net Income | 51.0M | 46.7M | 38.6M | 5.6M |
| Net Margin % | 29.4% | 22.7% | 19.9% | 3.2% |
| Key Metrics | ||||
| EBITDA | 74.2M | 88.5M | 86.3M | 30.9M |
| EPS (Basic) | - | $0.48 | $0.39 | $0.06 |
| EPS (Diluted) | - | $0.48 | $0.39 | $0.06 |
| Basic Shares Outstanding | - | 96561041 | 100743253 | 100743253 |
| Diluted Shares Outstanding | - | 96561041 | 100743253 | 100743253 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
SBC Medical Balance Sheet From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & Equivalents | 163.8M | 125.0M | 103.0M | 51.7M |
| Short-term Investments | 319.2K | - | 0 | 1.9M |
| Accounts Receivable | 29.9M | 30.3M | 35.1M | 13.1M |
| Inventory | 2.8M | 1.5M | 3.1M | 1.4M |
| Other Current Assets | 127.2K | 25.5K | 162.1K | 37.2K |
| Total Current Assets | 231.2M | 184.5M | 165.9M | 112.9M |
| Non-Current Assets | ||||
| Property, Plant & Equipment | 8.8M | 5.3M | 5.9M | 5.5M |
| Goodwill | 78.6M | 10.8M | 26.9M | 15.0M |
| Intangible Assets | 47.7M | 1.6M | 19.7M | 7.3M |
| Long-term Investments | - | - | - | - |
| Other Non-Current Assets | 21.4M | 30.2M | 15.2M | 25.4M |
| Total Non-Current Assets | 149.2M | 81.6M | 92.9M | 112.5M |
| Total Assets | 380.4M | 266.1M | 258.8M | 225.5M |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | 17.6M | 14.5M | 26.5M | 15.3M |
| Short-term Debt | 13.6M | 4.5M | 7.4M | 8.2M |
| Current Portion of Long-term Debt | - | - | - | - |
| Other Current Liabilities | 5.4M | 227.9K | 832.5K | 2.3M |
| Total Current Liabilities | 61.1M | 61.2M | 92.5M | 101.3M |
| Non-Current Liabilities | ||||
| Long-term Debt | 38.0M | 7.7M | 15.5M | 7.9M |
| Deferred Tax Liabilities | 16.4M | 926.0K | 6.0M | 7.3M |
| Other Non-Current Liabilities | 1.7M | 1.2M | 1.1M | 1.2M |
| Total Non-Current Liabilities | 56.0M | 9.9M | 22.5M | 16.4M |
| Total Liabilities | 117.1M | 71.1M | 115.0M | 117.6M |
| Equity | ||||
| Common Stock | 10.4K | 10.3K | 9.4K | 0 |
| Retained Earnings | 240.4M | 189.5M | 142.8M | 103.5M |
| Treasury Stock | 7.7M | 2.7M | 0 | - |
| Other Equity | - | - | - | - |
| Total Shareholders Equity | 263.3M | 195.0M | 143.8M | 107.9M |
| Key Metrics | ||||
| Total Debt | 51.6M | 12.2M | 22.9M | 16.1M |
| Working Capital | 170.1M | 123.3M | 73.5M | 11.7M |
Balance Sheet Composition
SBC Medical Cash Flow Statement From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | 51.0M | 46.7M | 38.6M | 5.6M |
| Depreciation & Amortization | 2.7M | 3.8M | 12.2M | 5.9M |
| Stock-Based Compensation | 0 | 13.0M | 0 | - |
| Working Capital Changes | -4.2M | -10.9M | -3.9M | -21.8M |
| Operating Cash Flow | 50.8M | 42.1M | 54.3M | -10.8M |
| Investing Activities | ||||
| Capital Expenditures | 4.8M | -3.4M | -1.5M | -22.7M |
| Acquisitions | -43.0M | -5.1M | 722.6K | -6.5M |
| Investment Purchases | -1.1M | -331.5K | -2.1M | -2.6M |
| Investment Sales | 457.8K | 0 | 4.1M | 0 |
| Investing Cash Flow | -21.0M | -10.1M | 3.5M | -32.7M |
| Financing Activities | ||||
| Share Repurchases | -5.0M | - | - | - |
| Dividends Paid | - | - | - | - |
| Debt Issuance | 34.8M | 12.1M | 12.3M | 124.2K |
| Debt Repayment | -1.7M | -119.0K | -8.7M | -5.2M |
| Financing Cash Flow | 38.3M | 22.9M | 6.1M | -8.0M |
| Free Cash Flow | 22.0M | 17.2M | 39.5M | -25.0M |
| Net Change in Cash | 68.1M | 54.9M | 63.9M | -51.4M |
Cash Flow Trend
SBC Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
6.80
Forward P/E
6.80
Price to Book
1.40
Price to Sales
2.01
PEG Ratio
6.80
Profitability Ratios
Profit Margin
29.37%
Operating Margin
32.47%
Return on Equity
22.28%
Return on Assets
13.05%
Financial Health
Current Ratio
3.78
Debt to Equity
19.61
Beta
0.99
Per Share Data
EPS (TTM)
$0.50
Book Value per Share
$2.42
Revenue per Share
$1.69
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SBC | 343.6M | 6.80 | 1.40 | 22.28% | 29.37% | 19.61 |
| Verisk Analytics | 24.4B | 27.34 | 79.33 | 437.95% | 29.56% | 1,581.80 |
| Equifax | 21.1B | 31.45 | 4.69 | 14.37% | 11.12% | 113.35 |
| Icf International | 1.2B | 13.78 | 1.21 | 9.11% | 4.89% | 55.75 |
| CRA International | 985.5M | 18.46 | 4.60 | 25.74% | 7.29% | 59.57 |
| Roma Green Finance | 335.3M | -2.74 | 31.92 | -38.87% | -219.17% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.






